全文获取类型
收费全文 | 1636篇 |
免费 | 134篇 |
国内免费 | 4篇 |
学科分类
医药卫生 | 1774篇 |
出版年
2021年 | 14篇 |
2020年 | 11篇 |
2019年 | 24篇 |
2018年 | 26篇 |
2017年 | 17篇 |
2016年 | 17篇 |
2015年 | 32篇 |
2014年 | 48篇 |
2013年 | 51篇 |
2012年 | 72篇 |
2011年 | 63篇 |
2010年 | 54篇 |
2009年 | 48篇 |
2008年 | 68篇 |
2007年 | 73篇 |
2006年 | 59篇 |
2005年 | 42篇 |
2004年 | 59篇 |
2003年 | 61篇 |
2002年 | 57篇 |
2001年 | 54篇 |
2000年 | 50篇 |
1999年 | 54篇 |
1998年 | 28篇 |
1997年 | 28篇 |
1996年 | 25篇 |
1995年 | 24篇 |
1994年 | 25篇 |
1993年 | 26篇 |
1992年 | 37篇 |
1991年 | 41篇 |
1990年 | 34篇 |
1989年 | 40篇 |
1988年 | 40篇 |
1987年 | 30篇 |
1986年 | 44篇 |
1985年 | 34篇 |
1984年 | 37篇 |
1983年 | 34篇 |
1982年 | 27篇 |
1981年 | 12篇 |
1980年 | 12篇 |
1979年 | 16篇 |
1978年 | 11篇 |
1977年 | 11篇 |
1976年 | 10篇 |
1975年 | 9篇 |
1972年 | 7篇 |
1970年 | 8篇 |
1937年 | 7篇 |
排序方式: 共有1774条查询结果,搜索用时 15 毫秒
21.
The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor 总被引:10,自引:0,他引:10
22.
23.
Harmon KS 《Positively aware : the monthly journal of the Test Positive Aware Network》1999,10(2):21-25
An examination of HIV, pregnancy, the risk of transmission from mother to child, and AZT use by pregnant women is provided. Current medical information on factors affecting the risk of HIV transmission from mother to child is addressed. The article emphasizes that HIV-positive pregnant women benefit from a good prenatal care program, and antiretroviral use. It further stresses that there are no hard-and-fast rules regarding treatment courses for pregnant women. Women making therapy choices should take the time to consider all their options before deciding their course of action. Final comments explore personal and social issues that often arise when an HIV-positive woman is considering pregnancy, or finds out she is HIV-positive after becoming pregnant. Contact information is provided. 相似文献
24.
25.
Wilk JB Premkumar S Nicolaou M Myers RH Maher NE Harmon MD Farrer LA DeStefano AL Cupples LA Couropmitree NN 《Genetic epidemiology》1999,17(Z1):S761-S766
Linkage analysis was performed on the GAW11 Problem 2 data set using stratification to explore the effects of the environmental risk factors and the differences between mild and severe phenotypes. Analysis of the four study populations stratified by the two risk factors identified regions on chromosomes 3 and 5 with significant evidence for linkage. Other loci were sought by removing families consistent with linkage to the chromosome 3 locus. Our studies identified a locus on chromosome 3 (markers 43-46) associated with the mild phenotype in the presence of risk factor 1 and with the severe phenotype independent of risk factor 1. This suggests that distinct allelic variants at the chromosome 3 locus may cause different forms of disease. The locus identified on chromosome 5 (markers 36-39) was linked to the severe phenotype, but exposure to factor 1 or 2 may have a protective effect. The regions on chromosomes 3 and 5 appeared to have independent roles in disease etiology. Evidence for two loci on chromosome 1 linked to the mild form was found. The methods successfully identified linkages and interaction consistent with the generating model. 相似文献
26.
M Spector R J Davis E M Lunceford S L Harmon 《Clinical orthopaedics and related research》1983,(176):34-41
Sixteen porous polysulfone-coated canine femoral stems were inserted into 14 dogs. Coatings were approximately 40% porous, with an average pore size of 125 or 250 microns. Bone was formed within at least about 30% of the surface pores of the implants. The tissue ingrowths filling the pores included marrow and fibrous tissue. Correlated roentgenographic and histologic observations revealed a trabecular "lamina dura" at the coating-bone interface and relatively dense trabeculae distal to the stem tip. These observations support the concept of coating femoral prostheses with porous material for cement-free stabilization. 相似文献
27.
Harmon S 《MLO: medical laboratory observer》1991,23(4):56-59
Allow yourself to learn from criticism directed at you. Even if it is invalid, respond diplomatically. Conclusion of a series on personal and personnel judgments in the lab. 相似文献
28.
29.
T D Moon E P Harmon R E Hurst R A Bass M Colcolough G P Hemstreet 《The Journal of urology》1991,145(6):1236-1237
Quantitative fluorescence image analysis incorporates the 2 diagnostic techniques of cytological analysis with quantitation of deoxyribonucleic acid (DNA). Exfoliated urinary cells are ideal for analysis by this method, which allows the identification of "rare event" abnormal cells. We evaluated the urine from 50 children who had undergone cystoscopy or were catheterized for other reasons. The urine was free of infection by urinalysis. Cytological analysis demonstrated normal or atypical cells in all patients. Of the patients 1 (2%) had greater than 2 of 500 cells analyzed with greater than 5C DNA and 4 (8%) had greater than 2 of 500 cells with greater than 5C double stranded nucleic acid. These data suggest that it may be "normal" for urine to contain "rare event" abnormal cells. The significance of this finding is unclear at present. 相似文献
30.
R Garcia-Carbonero J G Supko J Manola M V Seiden D Harmon D P Ryan M T Quigley P Merriam J Canniff G Goss U Matulonis R G Maki T Lopez T A Puchalski M A Sancho J Gomez C Guzman J Jimeno G D Demetri 《Journal of clinical oncology》2004,22(8):1480-1490
PURPOSE: To assess the efficacy of the marine-derived alkaloid ecteinascidin 743 (ET-743) in patients with soft tissue sarcomas that progressed despite prior conventional chemotherapy and to characterize the pharmacokinetic profiles of ET-743 in this patient population. PATIENTS AND METHODS: Thirty-six previously treated soft tissue sarcoma patients from three institutions received ET-743 as a 24-hour continuous intravenous (IV) infusion at a dose of 1,500 microg/m(2) every 3 weeks. Pharmacokinetic studies were also performed. Patients were restaged every two cycles for response by objective criteria. RESULTS: Objective responses were observed in three patients, with one complete response and two partial responses, for an overall response rate of 8% (95% CI, 2% to 23%). Responses were durable for up to 20 months. Two minor responses (43% and 47% tumor reduction) were observed, for an overall clinical benefit rate of 14%. The predominant toxicities were neutropenia and self-limited transaminitis of grade 3 to 4 severity in 34% and 26% of patients, respectively. The estimated 1-year time to progression and overall survival rates were 9% (95% CI, 3% to 27%) and 53% (95% CI, 39% to 73%), respectively. The maximum observed plasma concentration and total plasma clearance of ET-743 (mean +/- standard deviation), 1.04 +/- 0.48 ng/mL and 35.6 +/- 16.2 L/h/m(2), respectively, were consistent with previously reported values from phase I studies of the drug given as a 24-hour IV infusion. CONCLUSION: ET-743 is a promising new option for the management of several histologic subtypes of sarcoma. Durable objective responses were obtained in a subset of sarcoma patients with disease progression despite prior chemotherapy. Additionally, the relatively high survival rate noted in this series of previously treated patients further justifies development of this agent. 相似文献